Advisory Research Inc Ventyx Biosciences, Inc. Transaction History

Advisory Research Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$29.51 - $46.65 $91,274 - $144,288	-3,093 Reduced 9.21%	30,507 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $45,275 - $68,176	1,874 Added 5.91%	33,600 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $401,016 - $1.23 Million	31,726 New	31,726 $1.11 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $132M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.